Brief: Capricor Therapeutics Q3 EPS USD -0.54
Nov 10 (Reuters) - Capricor Therapeutics Q3 basic EPS USD -0.54. Q3 operating expenses USD 26.3 million Q3 net income USD -24.6 million
Nov 10 (Reuters) - Capricor Therapeutics Q3 basic EPS USD -0.54. Q3 operating expenses USD 26.3 million Q3 net income USD -24.6 million